Evidence map›Paper›PMID 31969985›Full record

ArticlePorcine health management2020

Evaluation of a zinc chelate on clinical swine dysentery under field conditions.

Frédéric Vangroenweghe, Liesbeth Allais, Ellen Van Driessche, Robbert van Berkel, Gerwen Lammers, Olivier Thas

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Porcine health management, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. SuccessfulPathogens (Basel, Switzerland) · 2025
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Frédéric VangroenwegheElanco, BU Food Animals, Plantijn en Moretuslei 1 - 3rd floor, 2018 Antwerpen, Belgium.ORCID 0000-0003-0569-9503
Liesbeth AllaisDGZ-Vlaanderen, Industrielaan 29, 8820 Torhout, Belgium.
Ellen Van DriesscheDGZ-Vlaanderen, Industrielaan 29, 8820 Torhout, Belgium.
Robbert van BerkelIntracare BV, Voltaweg 4, 5466 AZ Veghel, The Netherlands.
Gerwen LammersIntracare BV, Voltaweg 4, 5466 AZ Veghel, The Netherlands.
Olivier Thas4I-BioStat, Data Science Institute, Hasselt University, Campus Diepenbeek, Agoralaan gebouw D, 3590 Diepenbeek, Belgium.
HumanTotalCare (Netherlands) · NLRode Kruis-Vlaanderen · BEProvince of Antwerp · BEUniversity of Wollongong · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

resultsOral administration of zinc chelate resulted in improvement of general clinical signs from 3 days onwards in the ID-treated group combined with a significantly better total fecal score at 14 days post-treatment. Overall, average daily weight gain was better in the ID-treated group over the entire study period (0-14 days) and during the 8 days following the end of ID-treatment. A significant reduction (4.48 vs. 0.63 log

conclusionsZinc chelate - administered as a Zn-Na

Indexed as

Brachyspira hyodysenteriaeSwine dysenteryZinc chelate

Identifiers

PMID31969985
PMCPMC6964031
OpenAlexW3006743199

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.